In a Letter to the Editor published in the New England Journal of Medicine (NEJM) on July 20, epidemiologist Dr. Tracy Høeg, physician-scientist Dr. Vinay Prasad, and Dr. Ram Duriseti from Stanford School of Medicine stated that a 2021 Israeli study on Pfizer’s COVID-19 booster may have overestimated the vaccine’s effectiveness by concluding those who received a booster…

An Australian doctor suspended for speaking out on the harmful side effects of COVID-19 vaccines has appealed a High Court’s decision after it refused to adjudicate his lawsuit, which was filed against the country’s medical regulators. In August 2022, Dr. William Bay, a Queensland GP registrar, received a medical registration suspension notice from the Australian…

Around one-in-five Canadians are hesitant to get a future COVID-19 booster shot, with nearly 60 percent of those reluctant saying they had concerns with the vaccine’s safety, according to in-house research by the Department of Health. Respondents who were reluctant to get a COVID-19 booster dose cited concerns about the safety or potential side effects as…

A systematic review of 325 autopsies showing COVID-19 vaccination caused or significantly contributed to 74 percent of deaths was removed from The Lancet’s preprint SSRN server within 24 hours, adding to an increasing number of censored studies on the potential harms of COVID-19 vaccines. The study, published July 5, examined all autopsies published in peer-reviewed…

A sudden increase in Stevens-Johnson syndrome (SJS)—a rare and potentially fatal skin disorder—may be triggered by COVID-19, increased vaccination rates, or a lowered threshold caused by vaccines or previous infection, according to a large case series recently published in Burns. Researchers with the burns unit at Concord Repatriation General Hospital in Australia saw two to four cases…

Commentary Drug regulators and public health agencies have saturated the airways with claims that serious harms following COVID vaccination are “rare.” But there has been very little scrutiny of that claim by the media, and I could not find an instance where international agencies actually quantified what they meant by the term “rare” or provided a scientific…

Now that the pandemic has ended, researchers are urging regulatory agencies to consider the safety issues associated with the rapid approval of COVID-19 vaccines—and to correctly classify messenger RNA (mRNA) vaccines as gene therapy products (GTPs) to prevent pharmaceutical companies from bypassing regulatory standards. According to a paper published in Nature on June 22, COVID-19…

The U.S. government’s safety surveillance system monitoring COVID-19 vaccine adverse events is “woefully inadequate” and may be missing safety signals, according to researchers who say the U.S. Food and Drug Administration (FDA) made multiple decisions to ensure its first published analysis only identified known safety signals. In a peer-reviewed letter published June 16 in the…

A panel of the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) meets on COVID-19 vaccines at 12:30 p.m. ET on June 23. Dr. Fiona Havers (CDC/NCIRD), Dr. Romeo Galang (CDC/NCCDPHP), and Dr. Ruth Link-Gelles (CDC/NCIRD) will give updates on COVID-19 epidemiology and vaccine effectiveness. Dr. Jefferson Jones (CDC/NCIRD)…

A panel of the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) meets on COVID-19 vaccines at 12:30 p.m. ET on June 23. Dr. Fiona Havers (CDC/NCIRD), Dr. Romeo Galang (CDC/NCCDPHP), and Dr. Ruth Link-Gelles (CDC/NCIRD) will give updates on COVID-19 epidemiology and vaccine effectiveness. Dr. Jefferson Jones (CDC/NCIRD)…